Login
Subscribe
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy
The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.
The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.
FDA, drug development, biotech, regulation
Former FDA Commissioner Frank Young Dies
Jef Akst | Dec 2, 2019 | 2 min read
The physician-researcher laid the groundwork for genetic cloning and led the US Food and Drug Administration as the country faced the AIDS crisis in the 1980s.
FDA Approves 3-D–Printed Drug
Jef Akst | Aug 4, 2015 | 1 min read
The US Food and Drug Administration green lights the first medicine produced by a 3-D printer for use in the human body.
Lazarus Drugs
Kate Yandell | Feb 1, 2015 | 8 min read
While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.